Search clinical trials for: Lenvatinib Mesylate
Total 2073 results
-
Eisai Inc.Merck Sharp & Dohme LLCCompletedSolid TumorsUnited States, China, Belgium, Australia, Italy, Korea, Republic of, Germany, Netherlands, Poland, Romania, Thailand
-
Regina Elena Cancer InstituteUniversity of Pisa; University of Roma La Sapienza; University of Turin, Italy; Istituto Oncologico Veneto IRCCS and other collaboratorsRecruitingDifferentiated Thyroid Cancer | GenderItaly
-
Eisai Co., Ltd.Completed
-
Henan Cancer HospitalRecruiting
-
Eisai LimitedCompleted
-
Shanghai Junshi Bioscience Co., Ltd.Not yet recruitingIntrahepatic CholangiocarcinomaChina
-
Elizabeth K. Lee MDMerck Sharp & Dohme LLCRecruitingGynecologic Cancer | Ovarian Clear Cell CarcinomaUnited States
-
Shanghai Jiahui International HospitalShanghai Zhongshan HospitalRecruitingAdvanced Biliary Tract CarcinomaChina
-
City of Hope Medical CenterNational Cancer Institute (NCI)RecruitingStage II Pancreatic Cancer AJCC v8 | Stage III Pancreatic Cancer AJCC v8 | Stage IV Pancreatic Cancer AJCC v8 | Stage IIA Pancreatic Cancer AJCC v8 | Stage IIB Pancreatic Cancer AJCC v8 | Advanced Pancreatic Ductal Adenocarcinoma | Unresectable Pancreatic Ductal AdenocarcinomaUnited States
-
Academic and Community Cancer Research UnitedNational Cancer Institute (NCI)CompletedPoorly Differentiated Thyroid Gland Carcinoma | Recurrent Differentiated Thyroid Gland Carcinoma | Columnar Cell Variant Thyroid Gland Papillary Carcinoma | Follicular Variant Thyroid Gland Papillary Carcinoma | Metastatic Thyroid Gland Follicular Carcinoma | Metastatic Thyroid Gland Papillary... and other conditionsUnited States
-
RenJi HospitalNot yet recruitingHepatocellular Carcinoma | Liver Transplant; Complications | Liver Cancer | Portal Vein Thrombosis | Radiotherapy; ComplicationsChina
-
Memorial Sloan Kettering Cancer CenterCompletedHead and Neck Cancer | Head and Neck Squamous Cell Carcinoma | Head and Neck Carcinoma | Cutaneous Squamous Cell CarcinomaUnited States
-
Floor BackesEisai Inc.CompletedFallopian Tube Carcinoma | Recurrent Endometrial Cancer | Primary Peritoneal Carcinoma | Recurrent Ovarian CancerUnited States
-
Emory UniversityNational Cancer Institute (NCI); Merck Sharp & Dohme LLCRecruitingKidney Cancer | Stage III Renal Cell Cancer AJCC v8 | Stage IV Renal Cell Cancer AJCC v8United States
-
University of BolognaCompletedMyeloid Leukemia, Chronic, Chronic-PhaseItaly
-
Chengdu Zenitar Biomedical Technology Co., LtdCompletedDiffuse Large B Cell Lymphoma，DLBCLChina
-
Novartis PharmaceuticalsCompletedRefractory Desmoplastic Small Round Cell TumorsItaly
-
Jinling Hospital, ChinaRecruitingNeoplasms | Kidney Neoplasms | Carcinoma, Renal Cell | Urologic Neoplasms | Urogenital Neoplasms | Kidney Diseases | Urologic Diseases | Carcinoma | Antineoplastic Agents | Male Urogenital Diseases | Female Urogenital Diseases | Immune Checkpoint Inhibitors | Urogenital DiseasesChina
-
IlDong Pharmaceutical Co LtdCompletedHealthyKorea, Republic of
-
Fudan UniversityActive, not recruitingHepatocellular CarcinomaChina
-
Shanghai Junshi Bioscience Co., Ltd.Active, not recruitingAdvanced Hepatocellular Carcinoma (HCC)Italy, Poland, Singapore, United States, China, Ukraine
-
Shandong New Time Pharmaceutical Co., LTDRecruitingHepatocellular CarcinomaChina
-
Cancer Institute and Hospital, Chinese Academy...Active, not recruitingHepatocellular Carcinoma | Radiotherapy | LenvatinibChina
-
CStone PharmaceuticalsActive, not recruitingHepatocellular CarcinomaSpain, China, United States, Poland, Italy, Taiwan
-
Eisai Inc.CompletedThyroid CancerUnited States, Australia, France, Poland, United Kingdom, Italy
-
Shanghai Zhongshan HospitalActive, not recruitingCholangiocarcinoma, IntrahepaticChina
-
Immunovative Therapies, Ltd.Mirror Biologics, Inc.Recruiting
-
Eisai Inc.Completed
-
Eisai Co., Ltd.Completed
-
Peking Union Medical College HospitalCompletedCholangiocarcinoma | Biomarker | Combinational Immunotherapy | Liver Neoplasm Malignant PrimaryChina
-
Nanjing First Hospital, Nanjing Medical UniversityEnrolling by invitationMain Heading (Descriptor) TermsChina
-
Eisai LimitedCompletedAdvanced Solid TumorFrance
-
Calgent Biotechnology Co., LtdCompletedResistant or Refractory Solid TumorsUnited States, Taiwan
-
Eisai Korea Inc.CompletedBreast Cancer | Breast NeoplasmsKorea, Republic of
-
Eisai Inc.Approved for marketingMetastatic Breast CancerCanada, Belgium, France
-
Merz Pharmaceuticals GmbHTerminatedSubjective TinnitusUnited States, United Kingdom, Poland, Austria, Belgium, Brazil, Czech Republic, France, Germany, Mexico, Netherlands, Portugal, South Africa, Spain
-
Pathway Therapeutics, Inc.Completed
-
Merz Pharmaceuticals GmbHTerminatedMultiple Sclerosis | Nystagmus, Congenital | Nystagmus, AcquiredUnited Kingdom
-
Merz Pharmaceuticals GmbHCompleted
-
Centre Leon BerardCompletedGastrointestinal Stromal Tumors | Resected Gastrointestinal Stromal Tumors | Non-metastatic | High Risk of Recurrence | KIT Gene MutationFrance
-
Peking Union Medical College HospitalSun Yat-Sen Memorial Hospital of Sun Yat-Sen University; The Second Affiliated...RecruitingRecurrent Ovarian CarcinomaChina
-
Massachusetts Eye and Ear InfirmaryEisai Inc.RecruitingAdvanced Cancer | Differentiated Thyroid CancerUnited States
-
Tianjin Medical University Second HospitalRecruiting
-
National University Hospital, SingaporeEisai Co., Ltd.; Tan Tock Seng HospitalUnknown
-
Tianjin Medical University Cancer Institute and...Not yet recruitingResectable Hepatocellular Carcinoma
-
AkesoAkeso Pharmaceuticals, Inc.CompletedHepatocellular CarcinomaChina
-
Qilu Pharmaceutical Co., Ltd.Not yet recruitingAdvanced Renal Cell Carcinoma
-
Hunan Province Tumor HospitalRecruitingSmall-cell Lung CancerChina
-
Tianjin Medical University Cancer Institute and...Not yet recruitingResectable Hepatocellular CarcinomaChina
-
Yunfei YuanRecruitingHepatocellular Carcinoma | Transarterial ChemoembolizationChina